
CLPT
ClearPoint Neuro, Inc.
$12.03
+$0.83(+7.41%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$302.75M
Volume
499.20K
52W Range
$9.76 - $19.22
Target Price
$29.00
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $6.1M | $5.7M | $7.4M | $7.4M | $11.2M | $12.8M | $16.3M | $20.6M | $24.0M | $31.4M | ||
Total Revenue | $4.4M | $5.6M | $7.4M | $7.4M | $11.2M | $12.8M | $16.3M | $20.6M | $24.0M | $31.4M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $-2.0M | $-2.6M | $-2.9M | $-2.4M | $3.9M | $3.7M | $5.2M | $7.0M | $10.3M | $12.3M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $4.1M | $3.1M | $4.5M | $4.9M | $7.3M | $9.1M | $11.1M | $13.5M | $13.6M | $19.1M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $10.3M | $10.6M | $10.8M | $10.2M | $11.9M | $19.0M | $29.7M | $29.9M | $36.1M | $38.9M | ||
Research & Development | $2.0M | $2.6M | $2.8M | $2.3M | $2.8M | $4.7M | $9.3M | $10.9M | $11.7M | $12.4M | ||
Research Expense | $2.0M | $2.6M | $2.8M | $2.3M | $2.8M | $4.7M | $9.3M | $10.9M | $11.7M | $12.4M | ||
Selling, General & Administrative | $8.4M | $8.0M | $8.0M | $7.9M | $9.1M | $14.4M | $15.2M | $19.0M | $24.4M | $26.5M | ||
Selling & Marketing Expenses | $8.4M | $8.0M | $8.0M | $7.9M | $9.1M | $5.4M | $7.2M | $9.4M | $12.6M | $14.5M | ||
General & Administrative Expenses | -- | -- | -- | $-106.9K | $-100.0K | $9.0M | $8.0M | $9.6M | $11.8M | $12.0M | ||
Salaries & Wages | $-1.7M | $-959.6K | $-1.2M | $-1.2M | $-799.0K | $1.1M | $2.1M | $7.0M | $6.1M | $6.9M | ||
Depreciation & Amortization | -- | -- | -- | $-109.4K | $-100.0K | $100.0K | $5.2M | $100.0K | $200.0K | $200.0K | ||
Depreciation & Amortization | -- | -- | -- | $-109.4K | $-100.0K | $100.0K | $5.2M | $100.0K | $200.0K | $200.0K | ||
Other Operating Expenses | -- | -- | -- | -- | -- | $200.0K | $500.0K | $500.0K | $600.0K | $900.0K | ||
OPERATING INCOME | ||||||||||||
Operating income | $-6.2M | $-7.5M | $-6.3M | $-5.2M | $-4.6M | $-6.2M | $-13.4M | $-16.3M | $-22.4M | $-19.7M | ||
EBITDA | $-6.5M | $-7.5M | $-5.8M | $-4.6M | $-3.7M | $-4.8M | $-12.7M | $-15.6M | $-23.0M | $-18.5M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $1.3M | $1.1M | $872.9K | $980.4K | $955.0K | $1.4M | $973.0K | $81.0K | $-386.0K | $-872.0K | ||
Interest Income Operating | -- | $1.1M | -- | -- | -- | -- | -- | -- | -- | -- | ||
Intinc | $16.5K | $8.8K | -- | -- | -- | -- | -- | -- | -- | -- | ||
Net Non-Operating Interest Income/Expense | $-1.2M | $-1.1M | $-872.9K | $-980.4K | $-955.0K | $-1.4M | $-973.0K | $-81.0K | $386.0K | $872.0K | ||
Other Income/Expense | $-230.9K | $595.8K | $-41.4K | $-364 | $-9.0K | $-882.0K | $63.0K | $-22.0K | $29.0K | $40.0K | ||
Other Special Charges | $230.9K | $-595.8K | $16.7K | $364 | $9.0K | $882.0K | $-63.0K | $-22.0K | $-29.0K | $-40.0K | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | $1.3M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Special Income Charges | $-1.3M | -- | $24.7K | -- | -- | -- | -- | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-7.2M | $-8.1M | $-6.3M | $-5.2M | $-4.6M | $-5.3M | $-13.4M | $-16.4M | $-23.7M | $-20.4M | ||
Pre-Tax Income | $-8.4M | $-9.1M | $-7.2M | $-6.2M | $-5.5M | $-6.8M | $-14.4M | $-16.4M | $-22.1M | $-18.9M | ||
INCOME TAX | ||||||||||||
Tax Provision | -- | -- | -- | -- | -- | $-388.0K | $-1.6M | $-913.0K | $-1.2M | $-650.0K | ||
NET INCOME | ||||||||||||
Net Income | $-8.4M | $-9.1M | $-7.2M | $-6.2M | $-5.5M | $-6.8M | $-14.4M | $-16.4M | $-22.1M | $-18.9M | ||
Net Income (Continuing Operations) | $-8.4M | $-9.1M | $-7.2M | $-6.2M | $-5.5M | $-6.8M | $-14.4M | $-16.4M | $-22.1M | $-18.9M | ||
Net Income (Discontinued Operations) | $-8.4M | $-9.1M | $-7.2M | $-6.2M | $-5.5M | $-6.8M | $-14.4M | $-16.4M | $-22.1M | $-18.9M | ||
Net Income (Common Stockholders) | $-8.4M | $-9.1M | $-7.2M | $-6.2M | $-5.5M | $-6.8M | $-14.4M | $-16.4M | $-22.1M | $-18.9M | ||
Normalized Income | -- | -- | -- | -- | -- | -- | $-16.0M | -- | -- | -- | ||
TOTALS | ||||||||||||
Total Expenses | $8.3M | $8.0M | $7.9M | $7.7M | $15.8M | $22.8M | $34.8M | $36.9M | $46.4M | $51.1M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $1.9M | $2.8M | $7.7M | $10.9M | $13.2M | $15.8M | $20.7M | $24.2M | $24.6M | $27.0M | ||
Average Shares Outstanding (Diluted) | $1.9M | $3.1M | $7.7M | $11.0M | $13.2M | $15.8M | $20.7M | $24.2M | $24.6M | $27.0M | ||
Shares Outstanding | $91.7M | $3.6M | $10.7M | $11.1M | $15.5M | $20.7M | $23.7M | $24.6M | $27.0M | $27.6M | ||
Basic EPS | -- | -- | -- | -- | -- | $-0.43 | $-0.69 | $-0.68 | $-0.90 | $-0.70 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-0.43 | $-0.69 | $-0.68 | $-0.90 | $-0.70 | ||
Diluted EPS | $-4.48 | $-2.93 | $-0.93 | $-0.56 | $-0.42 | $-0.43 | $-0.69 | $-0.68 | $-0.90 | $-0.70 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-0.42 | -- | -- | $-0.68 | $-0.90 | $-0.70 | ||
OTHER METRICS | ||||||||||||
Acquired In Process Rn D | -- | -- | $24.7K | -- | -- | -- | -- | -- | -- | -- | ||
Acquired In Process Rn D Income | -- | -- | -- | $64.3K | -- | -- | -- | -- | -- | -- | ||
Acquisition Expense | -- | -- | -- | -- | -- | -- | $5.0M | -- | -- | -- | ||
Gain On Sale Of Business | -- | -- | $24.7K | -- | -- | -- | -- | -- | -- | -- | ||
Insurance And Claims | -- | -- | -- | -- | -- | $3.7M | -- | -- | -- | -- | ||
Interest Expense Operating | -- | -- | -- | -- | -- | $3.7M | -- | -- | -- | -- | ||
Other Gand A | -- | -- | -- | $-106.9K | $-100.0K | $9.0M | $8.0M | $9.6M | $11.8M | $12.0M | ||
Selling Expense | $8.4M | $8.0M | $8.0M | $7.9M | $9.1M | -- | -- | -- | -- | -- | ||
Restruct | $1.3M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | CLPT | $12.03 | +7.4% | 499.20K |
3 | ||||
4 | ||||
5 | ||||
6 |